Artificial intelligence in pathologic myopia: a review of clinical research studies

人工智能在病理性近视中的应用:临床研究综述

阅读:1

Abstract

Myopia is a significant global health challenge, with the incidence of pathologic myopia (PM) on the rise. PM-related fundus diseases have become a leading cause of irreversible blindness. Early detection and treatment are crucial for the prevention and control of myopia. Recent advancements in artificial intelligence (AI), particularly in machine learning and deep learning algorithms, have shown promising results in the field of PM in ophthalmology. This review explores the latest developments in AI technology for managing PM, emphasizing its role in screening and diagnosis, grading and classification, and predictive assessment. AI has shown significant potential for clinical application in PM management, enhancing its intelligent, precise, and efficient practices.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。